Effects of transcription factor
Cell migration inhibition
Enhancer of zeste homolog 2
Neuroblastoma
SOXC transcription factors
Journal
Annals of surgical treatment and research
ISSN: 2288-6575
Titre abrégé: Ann Surg Treat Res
Pays: Korea (South)
ID NLM: 101622895
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
22
01
2023
revised:
23
10
2023
accepted:
06
03
2024
medline:
10
5
2024
pubmed:
10
5
2024
entrez:
10
5
2024
Statut:
ppublish
Résumé
This study aimed to analyze the expression and prognosis of SRY-box transcription factor 11 (SOX11) in neuroblastoma (NB), as well as the biological function and potential regulatory mechanism of SOX11 in NB. Public RNA sequencing was used to detect the expression level of SOX11. The Kaplan-Meier curve and hazard ratios (HR) were used to determine the prognostic value of SOX11 in NB. Functional analyses were performed using CCK8, wound healing assay, and transwell invasion assay. Finally, the potential target genes of SOX11 were predicted by Harmonizonme (Ma'ayan Laboratory) and Cistrome Data Browser (Cistrome Project) database to explore the potential molecular mechanism of SOX11 in NB. Compared with normal adrenal tissue, the expression of SOX11 in NB tissue was significantly upregulated. The Kaplan-Meier curve showed that high expression of SOX11 was associated with poor prognosis in children with NB (HR, 1.719; P = 0.049). SOX11 knockdown suppressed the migration capacity of SK-N-SH cells but did not affect proliferation and invasion capacity. Enhancer of zeste homolog 2 ( The transcription factor SOX11 was significantly upregulated in NB. SOX11 knockdown suppressed the migration capacity of NB cell SK-N-SH. SOX11 may promote the progression of NB by targeting EZH2.
Identifiants
pubmed: 38725807
doi: 10.4174/astr.2024.106.5.284
pmc: PMC11076950
doi:
Types de publication
Journal Article
Langues
eng
Pagination
284-295Informations de copyright
Copyright © 2024, the Korean Surgical Society.
Déclaration de conflit d'intérêts
Conflict of Interest: No potential conflict of interest relevant to this article was reported.